In conclusion, we observed an altered profile of circulating peptides regulating appetite—especially nesfatin-1 and spexin—in non-obese children with Prader-Willi syndrome during growth hormone treatment and reduced energy intake. The gene discussed is NUCB2; the disease is Prader-Willi syndrome.